Catalina Capital Group LLC Raises Stake in Waldencast plc (NASDAQ:WALD)

Catalina Capital Group LLC increased its stake in Waldencast plc (NASDAQ:WALD) by 69.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,102 shares of the company’s stock after buying an additional 11,154 shares during the period. Catalina Capital Group LLC’s holdings in Waldencast were worth $109,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Renaissance Technologies LLC purchased a new position in shares of Waldencast during the second quarter worth approximately $239,000. Marshall Wace LLP bought a new position in Waldencast in the second quarter worth approximately $37,000. Cubist Systematic Strategies LLC purchased a new position in Waldencast during the 2nd quarter worth $85,000. Simplicity Wealth LLC raised its position in Waldencast by 416.2% during the 3rd quarter. Simplicity Wealth LLC now owns 77,080 shares of the company’s stock valued at $281,000 after purchasing an additional 62,148 shares in the last quarter. Finally, Bleakley Financial Group LLC lifted its holdings in shares of Waldencast by 75.2% in the 3rd quarter. Bleakley Financial Group LLC now owns 26,297 shares of the company’s stock worth $96,000 after buying an additional 11,288 shares during the period. Institutional investors own 41.97% of the company’s stock.

Analyst Ratings Changes

WALD has been the topic of several research reports. TD Cowen assumed coverage on Waldencast in a research note on Monday, December 16th. They set a “hold” rating and a $4.30 price target on the stock. Canaccord Genuity Group began coverage on shares of Waldencast in a research report on Friday, October 25th. They set a “buy” rating and a $5.00 target price on the stock. Canaccord Genuity Group upped their price target on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Friday, November 22nd. DA Davidson lifted their price objective on shares of Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a report on Wednesday, December 4th. Finally, Telsey Advisory Group reissued an “outperform” rating and issued a $6.00 price objective on shares of Waldencast in a research note on Monday, November 18th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $5.76.

Waldencast Stock Performance

Shares of Waldencast stock opened at $3.53 on Wednesday. Waldencast plc has a 52-week low of $2.40 and a 52-week high of $8.35. The firm’s 50 day moving average price is $3.45 and its 200-day moving average price is $3.41. The company has a quick ratio of 0.78, a current ratio of 1.47 and a debt-to-equity ratio of 0.21.

Waldencast Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.